Cargando…

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma

OBJECTIVES: Maintenance therapy with capecitabine after induction chemotherapy for patients with newly diagnosed metastatic nasopharyngeal carcinoma (mNPC) has been confirmed to be effective. This study aimed to evaluate the cost-effectiveness of capecitabine as maintenance therapy for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jiaqi, Lan, Xiaomeng, Tian, Kun, Shen, Xi, He, Jinlan, Chen, Nianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911043/ https://www.ncbi.nlm.nih.gov/pubmed/36777769 http://dx.doi.org/10.3389/fpubh.2022.1086393

Ejemplares similares

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
por: Xie, Qian, et al.
Publicado: (2022)

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
por: Xie, Qian, et al.
Publicado: (2022)

A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan
por: Su, Po‐Jung, et al.
Publicado: (2023)

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept
por: De Lorenzo, Stefania, et al.
Publicado: (2018)

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
por: Tomita, Yoshihiko, et al.
Publicado: (2022)

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer
por: Kim, Tae Won, et al.
Publicado: (2016)

Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients
por: Kitazawa, Haruna, et al.
Publicado: (2019)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
por: Casadei Gardini, Andrea, et al.
Publicado: (2017)

Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Zhong, Chenxi, et al.
Publicado: (2013)

Best Supportive Care of the Patient with Oesophageal Cancer
por: Pichel, Rita Carrilho, et al.
Publicado: (2022)

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer
por: Mubarak, Nabil, et al.
Publicado: (2012)

Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial
por: Nickols, Nicholas G., et al.
Publicado: (2021)

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer
por: Paz-Ares, Luis G, et al.
Publicado: (2010)

A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer
por: Wang, J, et al.
Publicado: (2011)

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study
por: Chen, Eric X., et al.
Publicado: (2020)

Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
por: Torregrosa, Cécile, et al.
Publicado: (2022)

A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.
por: Cascinu, S., et al.
Publicado: (1995)

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
por: Anderson, H, et al.
Publicado: (2000)

The need for a re-evaluation of best supportive care studies reported to date
por: Currow, D C, et al.
Publicado: (2011)

Best supportive care in clinical trials: review of the inconsistency in control arm design
por: Nipp, R D, et al.
Publicado: (2015)

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
por: Ferrara, Giovanni, et al.
Publicado: (2018)

Maintenance and reliability best practices /
por: Gulati, R. D.
Publicado: (2021)

Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
por: Li, Hongwei, et al.
Publicado: (2021)

Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia
por: Garcia-Manero, Guillermo, et al.
Publicado: (2016)

Best Care Anywhere
por: Longman, Phillip
Publicado: (2010)

Best Care Anywhere
por: Longman, Phillip
Publicado: (2012)

Development of Best Practice Guidelines for Primary Care to Support Patients Who Use Substances
por: Hartney, Elizabeth, et al.
Publicado: (2020)

m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma
por: Liu, Zijian, et al.
Publicado: (2022)

The Best Methods for Newly Claimed Areas
Publicado: (1921)

Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma
por: Liao, Wenjun, et al.
Publicado: (2021)

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.
por: Pyrhönen, S., et al.
Publicado: (1995)

Best Practices for remote assembly and maintenance
por: KERSHAW, Keith
Publicado: (2014)

End-of-life care in rural general practice: how best to support commitment and meet challenges?
por: Ding, Jinfeng, et al.
Publicado: (2019)

Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care
por: Kang, Dong-Won, et al.
Publicado: (2022)

BEST INTENTIONS OR BEST PRACTICE? HOW DO STAFF PERCEIVE BEST CARE FOR PEOPLE WITH DEMENTIA IN TAIWAN?
por: Liou, Chih-ling
Publicado: (2019)

Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yang, Jiangping, et al.
Publicado: (2020)

Prospective Randomized Phase II Parallel Study of Vinorelbine Maintenance Therapy versus Best Supportive Care in Advanced Non-Small Cell Lung Cancer
por: Khosravi, Adnan, et al.
Publicado: (2017)

Best care antibiotic stewardship
Publicado: (2019)

Reliability, maintainability, and supportability: best practices for systems engineers
por: Tortorella, Michael
Publicado: (2015)

Organizational Best Practices Supporting Mental Health in the Workplace
por: Wu, Ashley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ietm1hpavihp2du99ol02qhmma